Nokia Corporation (ADR) (NYSE:NOK) Appeal Will Start Again On 11 March; Samsung & Google Are Worried About Microsoft’s Bid
Last month, Nokia Corporation (ADR) (NYSE:NOK) filed a case in Supreme Court that the Delhi High Court had applied new terms and conditions over the transfer of the plant after unfreezing the assets before that. Today, the lawyer said that Supreme Court will start again a hearing on March 11 against a high court on new conditions that it imposed over transferring ownership of Nokia’s … Continue reading Nokia Corporation (ADR) (NYSE:NOK) Appeal Will Start Again On 11 March; Samsung & Google Are Worried About Microsoft’s Bid
Stocks To Watch on Analyst Actions: Revance Therapeutics Inc. (NASDAQ:RVNC), Brandywine Realty Trust (NYSE:BDN), Sodastream International Ltd. (NASDAQ:SODA)
Analysts at Janney Capital Markets have lowered their 2014 and 2015 earnings estimates for Chiquita Brands International Inc. (NYSE:CQB), while maintaining a neutral rating on the stock. The firm has lowered its 2014 EPS to $1.01 from $1.12, and reduced its 2015 EPS forecast to $1.25 from $1.29 a share. The estimate adjustment comes just a few days after Chiquita Brands International Inc. (NYSE:CQB) reported Q4 2013 … Continue reading Stocks To Watch on Analyst Actions: Revance Therapeutics Inc. (NASDAQ:RVNC), Brandywine Realty Trust (NYSE:BDN), Sodastream International Ltd. (NASDAQ:SODA)
Most Volatile Services Sector Stocks: YRC Worldwide (NASDAQ:YRCW), GasLog (NYSE:GLOG), FreeSeas Inc. (NASDAQ:FREE), Teekay Tankers (NYSE:TNK)
Trucking giant YRC Worldwide Inc. says it has refocused on business after being distracted for months by its labor deal and debt refinancing. YRC Worldwide, Inc. (NASDAQ:YRCW) stock performance was 0.77% in last session and finished the day at $26.20. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 1.28 million shares. The beta of the stock … Continue reading Most Volatile Services Sector Stocks: YRC Worldwide (NASDAQ:YRCW), GasLog (NYSE:GLOG), FreeSeas Inc. (NASDAQ:FREE), Teekay Tankers (NYSE:TNK)
Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)
Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)
Diversified Electronics: Advanced Energy Industries (NASDAQ:AEIS), Alliance Fiber Optic (NASDAQ:AFOP), Altair Nanotechnologies (NASDAQ:ALTI), American Superconductor (NASDAQ:AMSC)
Advanced Energy Industries, Inc. (NASDAQ:AEIS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $153 million versus the consensus estimate of $150.75 million. Advanced Energy Industries, Inc. (NASDAQ:AEIS) stock performance was -1.86% in last session and finished the day at $27.44. Traded volume was 0.00 shares in the last session and the average volume … Continue reading Diversified Electronics: Advanced Energy Industries (NASDAQ:AEIS), Alliance Fiber Optic (NASDAQ:AFOP), Altair Nanotechnologies (NASDAQ:ALTI), American Superconductor (NASDAQ:AMSC)
Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip
Array BioPharma (NASDAQ:ARRY) was up more than 9% in pre-market trade after reporting positive study results for its asthma treatment. The company said, ARRY-502, an oral CRTh2 antagonist, was studied in a 184-patient placebo-controlled, randomized, double-blind Phase 2 trial in mild to moderate persistent allergic asthma, a population representing more than 12 million patients in the U.S. ARRY-502 met the primary endpoint in the trial, … Continue reading Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip